Parallax Volatility Advisers’s NovoCure NVCR Stock Holding History

Parallax Volatility Advisers’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,700	Closed	-$160K	–	2196
2023 Q4	$160K	Buy	+10,700	New	+$143K	﹤0.01%	1813
2023 Q3	–	Sell	-11,200	Closed	-$465K	–	2506
2023 Q2	$465K	Sell	11,200 -33,000	-75%	-$2.05M	﹤0.01%	1664
2023 Q1	$2.66M	Sell	44,200 -15,000	-25%	-$1.2M	0.01%	1134
2022 Q4	$4.34M	Buy	+59,200	New	+$4.45M	0.01%	1087
2022 Q3	–	Sell	-400	Closed	-$28K	–	3277
2022 Q2	$28K	Buy	+400	New	+$30.1K	﹤0.01%	2547
2022 Q1	–	Sell	-1,000	Closed	-$75K	–	3031
2021 Q4	$75K	Sell	1,000 -1,900	-66%	-$191K	﹤0.01%	1783
2021 Q3	$337K	Buy	+2,900	New	+$438K	﹤0.01%	1599
2021 Q1	–	Sell	-92,400	Closed	-$16M	–	1986
2020 Q4	$16M	Sell	92,400 -25,100	-21%	-$3.43M	0.02%	589
2020 Q3	$13.1M	Buy	117,500 +34,300	+41%	+$2.74M	0.01%	881
2020 Q2	$4.94M	Sell	83,200 -88,500	-52%	-$5.82M	0.01%	1085
2020 Q1	$11.6M	Buy	+171,700	New	+$13.6M	0.01%	554
2018 Q3	–	Sell	-50,000	Closed	-$1.56M	–	3259
2018 Q2	$1.56M	Buy	+50,000	New	+$1.39M	﹤0.01%	976

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Parallax Volatility Advisers's NVCR Position: Q2 2024 in Review

Parallax Volatility Advisers sold out of NovoCure (NVCR) in Q2 2024, closing a stake of 10,183 shares — an estimated $159K sold.

Parallax Volatility Advisers first reported a position in NVCR in Q4 2017 and held it in 11 quarters. The position peaked at $3.69M in Q1 2020. 236 funds tracked by Wall St. Rank hold NVCR as of Q2 2024.

Parallax Volatility Advisers reported no remaining NovoCure position as of Q2 2024 after selling out during the quarter.
Parallax Volatility Advisers sold 10,183 NovoCure shares in Q2 2024, an estimated $159K.
Parallax Volatility Advisers first reported a position in NovoCure in Q4 2017 and held it in 11 quarters.
Parallax Volatility Advisers's NovoCure position peaked at $3.69M in Q1 2020.
236 funds tracked by Wall St. Rank held NovoCure as of Q2 2024.

Based on Parallax Volatility Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.